SCHEMBL26033641

SCHEMBL26033641

CCCN[C@@H](C)[C@H](C)CCC

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.33
METAP1 P53582 1/20 0.32
TSHR P16473 1/20 0.31
ADH1B P00325 1/20 0.31
ADH1A P07327 1/20 0.31
ADH7 P40394 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24709931 1.00 SIGMAR1 (0.33) SIGMAR1METAP1TSHRADH1BADH1A
SCHEMBL21131756 0.87 DNM1 (0.40) SIGMAR1TSHRADH1BADH1AADH7
SCHEMBL9210510 0.81 EPHX1 (0.41) SIGMAR1TSHRADH1BADH1AADH7
SCHEMBL22960955 0.81 SIGMAR1 (0.34) SIGMAR1
SCHEMBL24722286 0.81 METAP1 (0.33) METAP1TSHR
SCHEMBL19063319 0.81 METAP1 (0.33) METAP1TSHR
SCHEMBL19846890 0.80 SIGMAR1 (0.39) SIGMAR1ADH1BADH1AADH7
SCHEMBL24080219 0.77 SIGMAR1 (0.32) SIGMAR1
SCHEMBL25111650 0.75 METAP1 (0.39) SIGMAR1METAP1
SCHEMBL21695543 0.75 LMNA (0.33) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4234550-A2 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE Design Therapeutics, Inc. (US) 2023-08-30 EP disclosed